Joseph K. Wu

(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 817 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 491 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase

Jeffrey H. Toney, Paula M.D. Fitzgerald, Nandini Grover-Sharma et al. · Chemistry & Biology · 1998 · 239 citations · Full text

Pharmacy, Medicinal Chemistry, Microbiology +15

Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII

Barbara Leiting, KellyAnn D. Pryor, Joseph K. Wu et al. · Biochemical Journal · 2003 · 181 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes

Tesfaye Biftu, Ranabir SinhaRoy, Ping Chen et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16